SCHEMBL742270

SCHEMBL742270

O=C(O)c1cc(C2=NNNN2)cc(N2CCCC2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
KDM4E B2RXH2 3/20 0.44
GAA P10253 3/20 0.44
HSD17B10 Q99714 3/20 0.44
HPGD P15428 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
LOXL2 Q9Y4K0 2/20 0.37
TTR P02766 2/20 0.36
IP6K1 Q92551 2/20 0.36
IP6K3 Q96PC2 1/20 0.36
IP6K2 Q9UHH9 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
KDM5A P29375 1/20 0.33
KDM4C Q9H3R0 1/20 0.33
KDM5B Q9UGL1 1/20 0.33
P2RY14 Q15391 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL743462 0.85 NPC1 (0.38) ALDH1A1KDM4EGAAHSD17B10HPGD
SCHEMBL732579 0.74 ALDH1A1 (0.67) ALDH1A1KDM4EGAAHSD17B10HPGD
SCHEMBL730994 0.72 ALDH1A1 (0.46) ALDH1A1KDM4EGAAHSD17B10HPGD
SCHEMBL730914 0.71 ALDH1A1 (0.44) ALDH1A1KDM4EGAAHSD17B10HPGD
SCHEMBL12892181 0.69 TP53 (0.44) ALDH1A1KDM4EGAATTRNPC1
SCHEMBL21817818 0.68 ALDH1A1 (0.54) ALDH1A1KDM4EGAAHSD17B10HPGD
SCHEMBL594366 0.67 ALDH1A1 (0.57) ALDH1A1KDM4EGAAHSD17B10HPGD
SCHEMBL592613 0.66 KDM4E (0.56) ALDH1A1KDM4EGAAHSD17B10HPGD
SCHEMBL2724983 0.66 ALDH1A1 (0.56) ALDH1A1KDM4EGAAHSD17B10HPGD
SCHEMBL594127 0.66 KDM4E (0.56) ALDH1A1KDM4EGAAHSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138197-B2 Spirochromanon derivatives MSD K.K. (JP) 2012-03-20 US disclosed
US-8138197-B2 Spirochromanon derivatives MSD K.K. (JP) 2012-03-20 US disclosed
US-20090270436-A1 SPIROCHROMANON DERIVATIVES MERCK SHARP & DOHME LLC 2009-10-29 US disclosed
US-20090270436-A1 SPIROCHROMANON DERIVATIVES MERCK SHARP & DOHME LLC 2009-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270436-A1 SPIROCHROMANON DERIVATIVES AKR1C3, CBR3, AKR1C4 ALDH1A1 113/4885KDM4E 3445/4885GAA 3801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.